Comparing nerve blocks for pain management after shoulder surgery
Anterior Glenoid Nerve Block Versus Pericapsular Nerve Group (PENG) Block Versus Interscalene Brachial Plexus (ISB) Block for Postoperative Pain Management in Shoulder Arthroscopic Surgeries
NA · Ain Shams University · NCT06765278
This study is testing three different ways to block pain after shoulder surgery to see which one helps patients feel better and recover faster.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 49 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Ain Shams University (other) |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06765278 on ClinicalTrials.gov |
What this trial studies
This study compares three different nerve block techniques—Anterior Glenoid Nerve Block, Pericapsular Nerve Group Block, and Interscalene Brachial Plexus Block—for managing postoperative pain in patients undergoing shoulder arthroscopic surgeries. The aim is to determine which method provides the best pain relief while minimizing complications and promoting quicker recovery. The study utilizes ultrasound guidance for the PENG block, which is a newer technique that may offer advantages over the established ISB method. By improving pain management, the study seeks to enhance patient satisfaction and expedite rehabilitation.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 70 who are scheduled for shoulder arthroscopic surgeries and are classified as ASA physical status I-II.
Not a fit: Patients with a history of drug allergies to the study drugs, local infections, or neuromuscular pathologies may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved postoperative pain management strategies for patients undergoing shoulder surgeries.
How similar studies have performed: Previous studies have shown success with similar nerve block techniques, but the PENG block is a newer approach that is still being evaluated.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age from 18 to 70 years. * No sex predilection. * American Society of Anesthesiology (ASA) physical status I-II. * Undergoing shoulder arthroscopic surgeries. Exclusion Criteria: * Patient's refusal. * Patients with a history of drug allergies to study drugs. * Evidence of local infection at the site of injection. * Inability to cooperate * Neuromuscular pathology (example: - Multiple Sclerosis) * Previous trauma or surgery to the shoulder
Where this trial is running
Cairo
- Ain Shams University — Cairo, Egypt (RECRUITING)
Study contacts
- Study coordinator: Mohamed Serry, Master
- Email: mohamed.serry@med.asu.edu.eg
- Phone: 00201002609476
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Anterior Glenoid Nerve Block, Pericapsular Nerve Group Block, Interscalene Brachial Plexus Block, Postoperative Pain, Shoulder Arthroscopic Surgeries